<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

MARVEL on RT mutations at position 40


HIVdb Algorithm: Comments & Scores

    Mutation3TCFTCABCAZTD4TDDITDF
    Footnote:Mutation scores on the left are derived from published literature linking mutations and ARVs (the complete details can be found in the HIVdb Release Notes).
    Genotype-treatment correlation
    Mutation frequency according to subtype and drug-class experience.
    The frequency of each mutation at position 40 according to subtype and drug-class experience. Data are shown for the 8 most common subtypes. The number of persons in each subtype/treatment category is shown beneath the subtype. Mutations occurring at a frequency >0.5% are shown. Each mutation is also a hyper-link to a separate web page with information on each isolate, including literature references with PubMed abstracts, the GenBank accession number, and complete sequence and treatment records.

    PosWTRTI Naive Persons NRTI (but no NNRTI) Treated Persons
    A
    3215
    B
    22174
    C
    7465
    D
    1180
    F
    684
    G
    1316
    AE
    3654
    AG
    2607
     
    A
    172
    B
    4055
    C
    303
    D
    126
    F
    99
    G
    142
    AE
    325
    AG
    75
    40 E D 12 D 0.8 D 7.0 D 27
    A 0.6
    D 29 D 20 D 1.2 D 11  D 9.3  D 3.6 D 28
    F 0.9
    A 0.9
    D 22 D 7.4  D 6.8
    Footnote: The query page Mutation Prevalence According to Subtype and Treatment to examine the frequency of all mutations according to subtype and treatment; The program HIVSeq provides similar output for mutations in user-submitted sequences; A complete description of the program that generates these tables can be found at Rhee et al AIDS 2006.
     

    Mutation frequency according to treatment with individual ARVs.
    The first row shows the frequency of the mutation in persons who are RTI-naive (indicated in green). The second row shows the frequency of the mutation in persons who have received one or more NRTIs (+/- NNRTIs). The following rows show the frequency of the mutation in persons who have received only a single NRTI. Mutation rates that differ significantly between treated and untreated isolates are indicated in yellow.
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40A0039718390.00 
    E40A>=10532330.000.484
    E40A>=0>=113160100.000.575
    E40AAZT>=04520  
    E40ADDI>=0530  
    E40AD4T>=0540  
    E40AABC>=0450  
    E40A>=0NVP384850.100.745
    E40A>=0EFV24250  
    E40A>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40D003971823966.00 
    E40D>=1053231322.400.000
    E40D>=0>=1131605063.800.000
    E40DAZT>=0452245.300.587
    E40DDDI>=05311.800.328
    E40DD4T>=05435.500.890
    E40DABC>=04512.200.447
    E40D>=0NVP38483288.500.000
    E40D>=0EFV2425923.700.000
    E40D>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40F00397180  
    E40F>=105323160.300.000
    E40F>=0>=1131601300.900.000
    E40FAZT>=04520  
    E40FDDI>=0530  
    E40FD4T>=0540  
    E40FABC>=0450  
    E40F>=0NVP384880.200.000
    E40F>=0EFV242570.200.000
    E40F>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40G0039718320.00 
    E40G>=10532330.000.739
    E40G>=0>=11316050.000.158
    E40GAZT>=04520  
    E40GDDI>=0530  
    E40GD4T>=0540  
    E40GABC>=0450  
    E40G>=0NVP38480  
    E40G>=0EFV242520.000.737
    E40G>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40K0039718320.00 
    E40K>=10532370.100.348
    E40K>=0>=113160230.100.006
    E40KAZT>=04520  
    E40KDDI>=0530  
    E40KD4T>=0540  
    E40KABC>=0450  
    E40K>=0NVP3848120.300.000
    E40K>=0EFV242520.000.737
    E40K>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40Q0039718170.00 
    E40Q>=10532350.000.209
    E40Q>=0>=11316060.000.913
    E40QAZT>=04520  
    E40QDDI>=0530  
    E40QD4T>=0540  
    E40QABC>=0450  
    E40Q>=0NVP384830.000.563
    E40Q>=0EFV242510.000.638
    E40Q>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40R003971830.00 
    E40R>=1053230  
    E40R>=0>=11316040.000.124
    E40RAZT>=04520  
    E40RDDI>=0530  
    E40RD4T>=0540  
    E40RABC>=0450  
    E40R>=0NVP38480  
    E40R>=0EFV242530.100.000
    E40R>=0ETR00  
    MutationNRTINNRTINumSeqNumMut% Mutantp
    E40V003971860.00 
    E40V>=10532320.000.544
    E40V>=0>=11316050.000.219
    E40VAZT>=04520  
    E40VDDI>=0530  
    E40VD4T>=0540  
    E40VABC>=0450  
    E40V>=0NVP384820.000.323
    E40V>=0EFV24250  
    E40V>=0ETR00  
    Footnote: About one-half of the untreated isolates belong to non-subtype B isolates; About 20% of the treated isolates belong to non-subtype B isolates; A page containing summaries for all of the mutations at this position can be found here.

    Genotype-phenotype correlation
    Phenotypes of top 10 common patterns of drug resistance mutations with mutations at position 40.
    Mutation pattern data is not available for E40.

    A complete summary of additional in vitro susceptibility data for viruses with E40 obtained using other assays including the Antivirogram can be found here.

     

    Phenotypic coefficients using machine learning
    Least Square Regression (LSR) was used to learn the relative contribution of each mutation to the fold decrease in susceptibility for an ARV. The figure on the left (click to enlarge the figure) shows the regression coefficients (which correlate with the contribution to resistance) for the 23 nonpolymorphic NRTI-resistance mutations shown to contribute decreased susceptibility to at least one NRTI. A complete description of the method that generates this figure can be found at Rhee et al PNAS 2006.